Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Seattle › NPI 1700861580
Hospital

Uw Medicine Northwest

Uw Medicine Northwest was paid $5.71M by Medicaid between Jan 2018 and Dec 2019, across 280 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 17% of everything it billed.

33Billing provider infoUW MEDICINE NORTHWEST
SEATTLE, WA 98133
33aNPI1700861580assigned 12/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.71M
24GClaims303,950
24DCodes billed280
24AFirst – last monthJan 2018 – Dec 2019
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#38 of 49
Median peer was paid$20.06M
This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018153,789$2.85M
2019150,161$2.87M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 17% 3,439 3,136 $966K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.9% 5,744 5,252 $509K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.7% 8,334 7,670 $438K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.9% 5,894 5,525 $394K
74177 Computed tomography, abdomen and pelvis; with contrast material 4.4% 1,757 1,699 $250K
90870 4.3% 651 169 $245K
70450 Computed tomography, head or brain; without contrast material 3.8% 2,020 1,902 $217K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 3.0% 1,576 840 $170K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.4% 799 786 $139K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.3% 1,569 1,299 $129K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.0% 3,199 2,062 $116K
59025 Fetal non-stress test 2.0% 673 367 $114K
268 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.9% 4,523 $107K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.9% 1,119 $107K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.8% 565 $105K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.6% 466 $93K
80053 Comprehensive metabolic panel 1.6% 14,637 $91K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.5% 643 $86K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 930 $85K
93970 1.1% 738 $64K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.0% 3,095 $59K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 494 $59K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 209 $55K
76830 Ultrasound, transvaginal <1% 637 $53K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 597 $47K
10061 <1% 212 $41K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,942 $38K
52356 <1% 26 $35K
36415 Collection of venous blood by venipuncture <1% 21,747 $35K
71250 <1% 631 $34K
77063 Screening digital breast tomosynthesis, bilateral <1% 711 $32K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,058 $30K
71046 Radiologic examination, chest; 2 views <1% 4,476 $29K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 18,085 $28K
70551 Magnetic resonance imaging, brain; without contrast material <1% 192 $28K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 406 $28K
80048 Basic metabolic panel (calcium, ionized) <1% 4,575 $27K
93017 <1% 319 $24K
84443 Thyroid stimulating hormone (TSH) <1% 2,960 $24K
93978 <1% 712 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,528 $23K
76770 <1% 296 $21K
84484 <1% 3,872 $21K
97165 <1% 487 $20K
87631 <1% 1,546 $19K
76801 <1% 282 $19K
G0378 Hospital observation service, per hour <1% 1,016 $17K
97162 <1% 570 $17K
93971 <1% 126 $11K
87040 <1% 1,030 $11K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,044 $10K
83036 Hemoglobin; glycosylated (A1C) <1% 1,620 $10K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 143 $9K
83605 <1% 1,280 $9K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 667 $9K
85027 <1% 2,202 $9K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 75 $9K
80061 Lipid panel <1% 2,001 $9K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,815 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,211 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,062 $8K
86141 <1% 1,797 $8K
90715 <1% 459 $8K
86780 <1% 789 $7K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 254 $7K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 91 $7K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 100 $7K
70544 <1% 95 $7K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 470 $6K
73630 <1% 615 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,536 $6K
76642 <1% 74 $6K
82607 <1% 631 $6K
84439 <1% 587 $6K
86695 <1% 424 $5K
74018 <1% 817 $5K
87081 <1% 1,395 $5K
72100 <1% 502 $5K
72125 Computed tomography, cervical spine; without contrast material <1% 901 $5K
85379 <1% 735 $5K
82728 <1% 735 $4K
80076 <1% 1,008 $4K
84702 <1% 3,020 $4K
70486 <1% 132 $4K
73030 <1% 499 $4K
86803 <1% 878 $4K
83880 <1% 739 $4K
73610 <1% 542 $4K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 13 $4K
85652 <1% 1,534 $4K
73562 <1% 585 $4K
97166 <1% 99 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 95 $3K
87340 <1% 834 $3K
81001 <1% 7,635 $3K
97035 <1% 560 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 809 $3K
86696 <1% 424 $3K
94729 <1% 285 $3K
82105 <1% 254 $3K
12011 <1% 12 $3K
73502 <1% 295 $3K
94727 <1% 266 $3K
85610 <1% 4,111 $2K
82570 <1% 399 $2K
70549 <1% 44 $2K
83540 <1% 635 $2K
82746 <1% 434 $2K
73130 <1% 353 $2K
83735 <1% 1,495 $2K
29581 <1% 34 $2K
87800 <1% 519 $2K
86900 <1% 729 $2K
84466 <1% 600 $2K
80164 <1% 258 $2K
86850 <1% 747 $2K
87147 <1% 1,685 $2K
80047 <1% 348 $2K
87070 <1% 1,072 $2K
87522 Neg quan hep c or qual rna <1% 107 $2K
94060 <1% 65 $2K
86762 <1% 374 $2K
71045 Radiologic examination, chest; single view <1% 1,149 $2K
76937 <1% 27 $2K
93798 <1% 210 $1K
97116 <1% 84 $1K
97535 Self-care/home management training, each 15 minutes <1% 54 $1K
82950 <1% 432 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 2,575 $1K
96367 <1% 47 $1K
86038 <1% 254 $1K
73110 <1% 181 $1K
87077 <1% 791 $1K
87186 <1% 1,326 $1K
86706 <1% 338 $1K
82550 <1% 306 $1K
83690 <1% 3,050 $1K
97161 <1% 31 $1K
93975 <1% 71 $1K
86901 <1% 903 $977.45
12013 <1% 15 $925.24
J3490 Unclassified drugs <1% 4,579 $890.33
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,359 $880.15
87205 <1% 1,114 $851.54
84153 <1% 130 $838.12
84403 <1% 55 $830.56
72040 <1% 82 $815.65
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,646 $796.49
80178 <1% 90 $712.87
93922 <1% 27 $709.06
76536 <1% 12 $708.14
83516 <1% 116 $651.23
84550 <1% 241 $642.18
86431 <1% 172 $640.97
83970 <1% 40 $633.77
82365 <1% 72 $631.69
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,178 $620.99
93976 <1% 13 $606.87
82962 <1% 2,851 $600.69
73140 <1% 44 $525.23
86200 <1% 117 $517.16
86704 <1% 107 $500.93
93041 <1% 6,705 $414.02
85007 <1% 245 $409.56
73080 <1% 52 $398.45
72110 <1% 13 $379.43
85014 <1% 638 $353.85
87088 <1% 325 $328.51
73090 <1% 41 $325.22
82977 <1% 109 $320.30
88307 <1% 18 $313.98
86480 <1% 27 $297.20
94761 <1% 4,802 $284.73
82043 <1% 112 $266.38
73590 <1% 32 $262.69
77067 Screening mammography, bilateral, including computer-aided detection <1% 716 $237.78
85730 <1% 1,241 $232.92
77066 Tomosynthesis, mammo <1% 13 $224.99
87075 <1% 451 $224.50
81025 <1% 1,265 $218.49
84100 <1% 285 $197.46
81003 <1% 117 $184.23
90632 <1% 16 $182.88
71101 <1% 30 $182.68
C9399 Unclassified drugs or biologicals <1% 381 $179.67
82150 <1% 65 $178.21
84481 <1% 30 $170.46
84156 <1% 49 $155.62
83520 <1% 31 $148.39
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 12 $141.41
J1170 Injection, hydromorphone, up to 4 mg <1% 1,801 $137.41
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,647 $130.21
J2704 Injection, propofol, 10 mg <1% 3,421 $126.67
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,521 $121.08
86481 <1% 12 $120.58
80069 <1% 14 $118.26
86160 <1% 26 $110.21
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 188 $109.39
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 423 $107.63
82947 <1% 39 $106.38
85018 <1% 717 $100.44
90686 <1% 13 $98.32
G0008 Administration of influenza virus vaccine <1% 12 $88.11
82565 <1% 118 $79.91
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,452 $77.71
82948 <1% 560 $66.32
C1781 Mesh (implantable) <1% 30 $58.99
J0690 Injection, cefazolin sodium, 500 mg <1% 1,813 $55.83
86765 <1% 12 $51.56
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,701 $50.31
87015 <1% 29 $49.91
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 560 $47.62
84165 <1% 12 $44.05
87493 <1% 39 $42.27
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 667 $42.20
86225 <1% 12 $40.96
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,140 $40.44
85004 <1% 12 $38.67
94760 <1% 560 $37.48
87427 <1% 21 $33.47
88304 <1% 178 $31.71
86308 <1% 14 $29.81
87045 <1% 12 $27.59
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 285 $25.10
82803 <1% 61 $23.68
J2270 Injection, morphine sulfate, up to 10 mg <1% 982 $21.79
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,638 $20.58
J7120 Ringers lactate infusion, up to 1000 cc <1% 583 $20.28
87184 <1% 12 $18.81
87102 <1% 13 $15.63
J1650 Injection, enoxaparin sodium, 10 mg <1% 803 $14.90
J2550 Injection, promethazine hcl, up to 50 mg <1% 315 $14.17
87046 <1% 12 $13.76
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,217 $13.56
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 532 $12.64
88342 <1% 29 $11.00
J1644 Injection, heparin sodium, per 1000 units <1% 825 $10.15
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 288 $8.52
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,179 $7.78
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,101 $7.73
J2060 Injection, lorazepam, 2 mg <1% 949 $7.45
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 489 $6.18
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 377 $6.13
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 555 $5.07
87806 <1% 529 $4.18
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,247 $3.60
84520 <1% 49 $3.57
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 307 $1.29
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 449 $1.22
96376 <1% 750 $0.76
J3475 Injection, magnesium sulfate, per 500 mg <1% 141 $0.29
J7030 Infusion, normal saline solution , 1000 cc <1% 528 $0.26
C1769 Guide wire 0% 742 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 153 $0.00
J8501 Aprepitant, oral, 5 mg 0% 156 $0.00
A9270 Non-covered item or service 0% 2,518 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 55 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 473 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 118 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 26 $0.00
72147 0% 13 $0.00
J1815 Injection, insulin, per 5 units 0% 466 $0.00
87176 0% 25 $0.00
72142 0% 74 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 14 $0.00
C9290 Injection, bupivacaine liposome, 1 mg 0% 13 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 563 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 946 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 209 $0.00
C1758 Catheter, ureteral 0% 197 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 247 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 66 $0.00
51701 0% 29 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 203 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 55 $0.00
82010 0% 12 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 13 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 38 $0.00
Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml 0% 15 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFERGUSON, BRUCE (VP/CHIEF FINANCIAL OFFICER)